|
Delayed
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 21-01-19 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
| 20-12-22 | ACell, Inc. Announces CE Mark Approval | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 2019-12-31 |
Patty Meehan
ADM | Chief Administrative Officer | - | 2001-12-31 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kyle C. Kerbawy
CHM | Chairman | 79 | 2015-07-31 |
Sally L. Maher
BRD | Director/Board Member | - | 2019-04-30 |
| Director/Board Member | 71 | 2019-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 340M | |
| +1.08% | +5.17% | -15.57% | +5.32% | 190B | |
| +0.09% | +5.29% | -2.14% | +8.76% | 116B | |
| -5.90% | +2.58% | +8.07% | +67.67% | 63.71B | |
| -0.91% | +0.33% | +34.28% | +58.74% | 55.13B | |
| +1.20% | +7.91% | -4.63% | -34.97% | 49.41B | |
| +1.42% | +4.44% | +16.63% | -18.70% | 33.79B | |
| +1.31% | -15.56% | - | - | 30.74B | |
| +0.26% | +1.01% | +46.59% | -10.75% | 24.73B | |
| +0.89% | +11.86% | -5.01% | +19.22% | 23.85B | |
| Average | -0.26% | +2.73% | +9.78% | +11.91% | 58.76B | |
| Weighted average by Cap. | -0.64% | +4.03% | +1.02% | +13.31% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 89.22M 77.41M 72.57M 66.11M 124M 8.5B 126M 855M 333M 4.26B 335M 328M 14.22B | 101M 87.45M 81.98M 74.69M 141M 9.61B 143M 966M 376M 4.81B 378M 370M 16.06B |
| Net income | -3.13M -2.72M -2.55M -2.32M -4.37M -298M -4.43M -30.01M -11.69M -149M -11.76M -11.5M -499M | 1.45M 1.26M 1.18M 1.07M 2.02M 138M 2.05M 13.88M 5.41M 69.16M 5.44M 5.32M 231M |
| Net Debt | - | - |
Employees
-
- Stock Market
- Stocks
- ACLL Stock
Select your edition
All financial news and data tailored to specific country editions
